Quantcast

Marinus Pharmaceuticals prices IPO at $8, well below the $12-$14 range


Shutterstock photo

Marinus Pharmaceuticals, an early-stage biotech developing an add-on therapy for epilepsy, raised $45 million by offering 5.6 million shares at $8, well below the $12-$14 range. Marinus Pharmaceuticals will list on the NASDAQ under the symbol MRNS. Marinus Pharmaceuticals initially filed confidentially on April 4, 2014. Stifel and JMP Securities acted as joint bookrunners on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.





This article appears in: News Headlines , IPOs
Referenced Symbols: MRNS




More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs












Research Brokers before you trade

Want to trade FX?